Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leiyuan Chen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|April 23, 2026
Integrated profiling of RUNX3 in intratumoral NK cells activity through bulk and single-cell transcriptomic analysisGuofu Lin, Lanlan Lin, Jincan Zhang, et al.
Bioscience Reports|August 2, 2019
Genetic polymorphism and transcriptional regulation of <i>CREBBP</i> gene in patient with diffuse large B-cell lymphomaHaifeng Zhao, Yutian Kan, Xinyuan Wang, et al.
BMC Cancer|March 6, 2025
Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapyZhiheng Lai, Yanyang Pang, Yujing Zhou, et al.
Cell Death & Disease|December 27, 2025
A new strategy for CAR-T therapy in solid tumors: IL-15-autocrine signaling augments tumor stroma depletion and promotes a T<sub>SCM</sub> subset in the TMEYanyang Pang, Leiyuan Chen, Qinghui Sun, et al.
Clinical and Experimental Medicine|August 24, 2021
Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphomaZhengzi Qian, Leiyuan Chen, Xinyuan Wang, et al.
ACS Nano|December 26, 2025
Surface Reconstruction and Orthogonal Decoupling in SrAl<sub>4</sub> and EuAl<sub>4</sub>Tongrui Li, Leiyuan Chen, Jian Yuan, et al.
Oncology Letters|April 10, 2020
miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphomaXinyuan Wang, Yutian Kan, Leiyuan Chen, et al.
Oncology Letters|August 25, 2020
Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphomaLeiyuan Chen, Yutian Kan, Xinyuan Wang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|April 23, 2026
Integrated profiling of RUNX3 in intratumoral NK cells activity through bulk and single-cell transcriptomic analysisGuofu Lin, Lanlan Lin, Jincan Zhang, et al.
Bioscience Reports|August 2, 2019
Genetic polymorphism and transcriptional regulation of <i>CREBBP</i> gene in patient with diffuse large B-cell lymphomaHaifeng Zhao, Yutian Kan, Xinyuan Wang, et al.
BMC Cancer|March 6, 2025
Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapyZhiheng Lai, Yanyang Pang, Yujing Zhou, et al.
Cell Death & Disease|December 27, 2025
A new strategy for CAR-T therapy in solid tumors: IL-15-autocrine signaling augments tumor stroma depletion and promotes a T<sub>SCM</sub> subset in the TMEYanyang Pang, Leiyuan Chen, Qinghui Sun, et al.
Clinical and Experimental Medicine|August 24, 2021
Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphomaZhengzi Qian, Leiyuan Chen, Xinyuan Wang, et al.
ACS Nano|December 26, 2025
Surface Reconstruction and Orthogonal Decoupling in SrAl<sub>4</sub> and EuAl<sub>4</sub>Tongrui Li, Leiyuan Chen, Jian Yuan, et al.
Oncology Letters|April 10, 2020
miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphomaXinyuan Wang, Yutian Kan, Leiyuan Chen, et al.
Oncology Letters|August 25, 2020
Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphomaLeiyuan Chen, Yutian Kan, Xinyuan Wang, et al.
Pageof 1